购物车
您的购物车当前为空
别名 PIG61, NISBD2, mENA, HER1, ERBB1, ERBB, epidermal growth factor receptor
EGFR Protein, Human, Recombinant (Isoform vIII, His & Avi), Biotinylated is expressed in HEK293 mammalian cells with His and Avi tag. The predicted molecular weight is 41.90 kDa and the accession number is NP_001333870.1.

EGFR Protein, Human, Recombinant (Isoform vIII, His & Avi), Biotinylated is expressed in HEK293 mammalian cells with His and Avi tag. The predicted molecular weight is 41.90 kDa and the accession number is NP_001333870.1.
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 5 μg | ¥ 1,350 | 6-8日内发货 | |
| 10 μg | ¥ 2,270 | 6-8日内发货 | |
| 20 μg | ¥ 3,820 | 5日内发货 | |
| 50 μg | ¥ 5,930 | 5日内发货 | |
| 100 μg | ¥ 9,870 | 5日内发货 |
| 产品描述 | EGFR Protein, Human, Recombinant (Isoform vIII, His & Avi), Biotinylated is expressed in HEK293 mammalian cells with His and Avi tag. The predicted molecular weight is 41.90 kDa and the accession number is NP_001333870.1. |
| 生物活性 | 1.Immobilized Anti-EGFR (Cetuximab biosimilar) at 2 μg/mL (100 μL/well) can bind Recombinant Human EGFR Protein (Isoform vIII, Avi & His Tag) (Cat#TMPY-06593), the EC50 is 0.5-1.5 ng/mL (QC tested). 2.Immobilized Anti-EGFR (Cetuximab Biosimilar) at 1 μg/mL (100 μL/well) can bind Recombinant Human EGFR Protein (Isoform vIII, Avi & His Tag) (Cat#TMPY-06593), the EC50 is 1.5 ng/mL(Routinely tested). |
| 研究背景 | As a member of the epidermal growth factor receptor (EGFR) family, EGFR protein is type I transmembrane glycoprotein that binds a subset of EGF family ligands including EGF, amphiregulin, TGF-α, betacellulin, etc. EGFR protein plays a crucial role in signaling pathway in the regulation of cell proliferation, survival and differentiation. Binding of a ligand induces EGFR protein homo- or heterodimerization, the subsequent tyrosine autophosphorylation and initiates various down stream pathways (MAPK, PI3K/PKB and STAT). In addition, EGFR signaling also has been shown to exert action on carcinogenesis and disease progression, and thus EGFR protein is proposed as a target for cancer therapy currently.Cancer ImmunotherapyImmune CheckpointImmunotherapyTargeted Therapy |
| 种属 | Human |
| 表达系统 | HEK293 Cells |
| 标签 | His, Avi |
| 蛋白编号 | NP_001333870.1 |
| 蛋白构建 | A DNA sequence encoding the human EGFR (NP_001333870.1) (Met1-Ser378) was expressed with a c-terminal polyhistidine tagged AVI tag at the C-terminus. The expressed protein was biotinylated in vivo by the Biotin-Protein ligase (BirA enzyme) which is co-expressed. Predicted N terminal: Leu 25 |
| 蛋白纯度 | > 95 % as determined by SDS-PAGE. > 95 % as determined by SEC-HPLC. |
| 蛋白性状 | Lyophilized powder |
| 缓冲液 | Lyophilized from a solution filtered through a 0.22 μm filter, containing PBS, pH 7.4. Typically, a mixture containing 5% to 8% trehalose, mannitol, and 0.01% Tween 80 is incorporated as a protective agent before lyophilization. |
| 复溶方法 | A Certificate of Analysis (CoA) containing reconstitution instructions is included with the products. Please refer to the CoA for detailed information. |
| 别名 | PIG61, NISBD2, mENA, HER1, ERBB1, ERBB, epidermal growth factor receptor |
| 内毒素 | < 1.0 EU/μg of the protein as determined by the LAL method. |
| 分子量 | 41.90 kDa (predicted); 64.45 kDa (reducing conditions) |
| 运输方式 | In general, lyophilized powders are shipped with blue ice, while solutions are shipped with dry ice. |
| 存储 |
对于不同动物的给药剂量换算,您也可以参考 更多